[324 Pages Report] The global catheter-directed thrombolysis market is valued at US$ 454.8 million in 2023. The market is likely to grow at a CAGR of 5.9% and is anticipated to be valued at US$ 808 million by 2033.
The demand for catheter-directed thrombolysis is anticipated to increase as the treatment makes use of processes that remove the clot be it based on thrombosis or embolization, the low time duration of treatment, and many other factors. This process is one of the most important preferred methods to treat stroke and related health issues.
Report Attributes | Details |
---|---|
Catheter-Directed Thrombolysis Market Value (2023) | US$ 454.8 million |
Catheter-Directed Thrombolysis Market Anticipated Value (2033) | US$ 808 million |
Catheter-Directed Thrombolysis Market Projected Growth Rate (2023 to 2033) | 5.9% |
Even if we compare the historical CAGR with the anticipated CAGR of the forecast period, there is a positive indication for the market. The historical CAGR of the catheter-directed thrombolysis industry from 2018 to 2022 was 4.9%, while the anticipated CAGR is 5.9%. The good thing is that the market is progressing because of the number of benefits catheter-directed thrombolytic therapy offers.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The seamlessness that this process offers is almost unmatchable. The entire process is done under the purview of X-ray imaging to get the correct site of the clot. Moreover, the technique is used for several treatments, which include thrombosis in the vascular bed, deep vein thrombosis, and thrombosis of dialysis fistulate. This is expected to increase the adoption of catheter-directed thrombolysis and makes the entire process an essential form of stroke medication.
Additionally, on comparing with the traditional heart surgery process, the process is extremely safe, and the duration for which the patient is admitted to the hospital is less. Besides that, based on the stats provided by WHO, it was found that around 17.9 million people died from heart disease in 2019, accounting for 32% of global deaths. This is something that has captured the attention of investors in the catheter-directed thrombolysis industry, as these are mainly used for treating heart diseases.
Furthermore, the availability of emergency medical services and favorable health insurance coverage will also fuel the catheter-directed thrombolysis industry. All these are anticipated to have a positive impact on the catheter-directed thrombolysis market trends and forecasts. However, the application of an IV line to administer anesthesia might lead to certain injuries to the skin. This can be a cause of concern for the catheter-directed thrombolysis industry.
The amazing ability to keep real-time track of the movements inside the body part has been made possible because of fluoroscopy. The application of fluoroscopy has been perceived as a life-saving surgical treatment. Apart from showing the real-time view, this method also helps medical practitioners to place the catheters inside the body with precision.
Moreover, fluoroscopy is used in a wide variety of examinations like Barium x-rays, placement of stents, and orthopedic surgery to carry out a variety of treatments which include viewing the gastrointestinal tract, visualizing blood vessels, guiding joint replacements, etc. Thus, from the above, it can be inferred that the usage of fluoroscopy is likely to increase the scope of the catheter-directed thrombolysis industry.
Attributes | Details |
---|---|
Replacing X-rays with Ultrasounds | Continuous exposure to X-rays can lead to health complications. Instead of this, the manufacturers can look for ways to replace X-rays with ultrasound, as these can be applied to any kind of patient, even pregnant women. Moreover, there are no side effects associated with the usage of ultrasounds, and the image quality provided by the usage of ultrasounds is also good. Thus, the replacement of X-rays with ultrasound might very well improve the catheter-directed thrombolysis industry outlook. |
Replacing the IV method with other methods | Instead of applying an invasive technique to administer anesthesia, the administration can be done through other methods, like administering it in the form of a gas, topical liquid, or any injection. The problem associated with intravenous medication is that it can lead to infection and damage the site of veins and may also lead to air embolism. However, replacing the IV line with anesthesia through gas, topical liquid, or injection is expected to avoid any instances of developing a skin infection or any other kind of complication as these are not pierced into the skin, thereby making the process fully non-invasive, except for the case of injection. The application of any one of these methods can be a positive step for the catheter-directed thrombolysis market. |
Attributes | Details |
---|---|
North America | North America is expected to dominate the catheter-directed thrombolysis industry share due to easy access to advanced healthcare facilities. According to Future Market Insights, the North American catheter-directed thrombolysis market has a market share of 53.4% and is expected to grow at a rapid pace during the forecast period. Moreover, the region is meant for rapid technological advances. According to World Health Organization (WHO), approximately 900,000 people were diagnosed with pulmonary embolism and deep vein thrombosis in the USA. in 2015. Among all end users, the hospital segment dominates the market for catheter-directed thrombolysis over the forecast period. The majority of cases of pulmonary embolism and deep vein thrombosis are treated in hospitals. |
Europe | Europe is considered to be the 2nd largest market for catheter-directed thrombolysis owing to the presence of a robust reimbursement scenario and improved regulatory framework. According to Future Market Insights, the region has a market share of 24.1% and is expected to grow significantly during the forecast period. Catheter-directed thrombolysis (CDT) with assisted mechanical thrombolysis in the region is considered the standard form of treatment. Deep vein thrombosis (DVT) is the third most common cardiovascular pathology after coronary artery disease and stroke in the region. Due to the growing geriatric population and risk factors that include oral contraceptives, the demand for catheter-directed thrombolysis is expected to increase during the forecast period in Europe. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Start-ups are developing new products with their unique ideas to solve several problems, especially in medical fields for patients. Start-ups in the catheter-directed thrombolysis industry are making new devices that help to prevent cardiovascular disease. Some of the start-ups are:
Corvus Medical:
Corveus Medical is a US-based start-up company that has developed a new device to prevent heart failure in recent years. The innovative device developed by a company named “neuromodulation device” helps to access heart tissues uniquely and safely.
Moray Medical:
Moray Medical is another US-based start-up that improves leaky heart valves by providing microfluidic robotic methods. The start-up treats its patients safely with cost-effective therapies.
The market is consolidated by the prominent vendors present all around the region in recent years. They are using several marketing tactics to acquire lion’s share and are anticipated to grow the catheter-directed thrombolysis market share during the forecast period.
Some of the marketing methodologies adopted by key players are partnerships, acquisitions, mergers, product launches, and collaborations among others. Global players such as Angio Dynamics, Inc. and Boston Scientific Corporation account for a considerable market size. Several regional-level players are also operating across key growth regions.
Recent Developments in the Catheter-Directed Thrombolysis Market:
Report Attributes | Details |
---|---|
Growth Rate | CAGR of 5.9% from 2023 to 2033 |
Base Year for Estimation | 2022 |
Historical Data | 2018 to 2022 |
Forecast Period | 2023 to 2033 |
Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
The market is valued at US$ 454.8 million by 2023.
The market is predicted to reach a size of US$ 808 million by 2033.
United States to hold sizeable share in the market.
A CAGR of 5.9% is predicted for the market by 2033.
From 2018 to 2022, the market registered a CAGR of 4.9%.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Delivery Mode 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Delivery Mode, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Delivery Mode, 2023 to 2033 5.3.1. Direct Delivery to Blood Clot Catheter-directed Thrombolysis 5.3.2. by Positioning Medical Device at Clot Site 5.4. Y-o-Y Growth Trend Analysis By Delivery Mode, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Delivery Mode, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023 to 2033 6.3.1. Pulmonary Embolism (PE) 6.3.2. Deep Vein Thrombosis (DVT) 6.3.3. Strokes 6.3.4. Other Indications 6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033 7.3.1. Hospitals 7.3.2. Surgical Centers 7.3.3. Radiology Clinics 7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA. 9.2.1.2. Canada 9.2.2. By Delivery Mode 9.2.3. By Indication 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Delivery Mode 9.3.3. By Indication 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Delivery Mode 10.2.3. By Indication 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Delivery Mode 10.3.3. By Indication 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Delivery Mode 11.2.3. By Indication 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Delivery Mode 11.3.3. By Indication 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Delivery Mode 12.2.3. By Indication 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Delivery Mode 12.3.3. By Indication 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Delivery Mode 13.2.3. By Indication 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Delivery Mode 13.3.3. By Indication 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Delivery Mode 14.2.3. By Indication 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Delivery Mode 14.3.3. By Indication 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Delivery Mode 15.2.3. By Indication 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Delivery Mode 15.3.3. By Indication 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Delivery Mode 16.1.2.2. By Indication 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Delivery Mode 16.2.2.2. By Indication 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Delivery Mode 16.3.2.2. By Indication 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Delivery Mode 16.4.2.2. By Indication 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Delivery Mode 16.5.2.2. By Indication 16.5.2.3. By End User 16.6. United Kingdom. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Delivery Mode 16.6.2.2. By Indication 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Delivery Mode 16.7.2.2. By Indication 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Delivery Mode 16.8.2.2. By Indication 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Delivery Mode 16.9.2.2. By Indication 16.9.2.3. By End User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Delivery Mode 16.10.2.2. By Indication 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Delivery Mode 16.11.2.2. By Indication 16.11.2.3. By End User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Delivery Mode 16.12.2.2. By Indication 16.12.2.3. By End User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Delivery Mode 16.13.2.2. By Indication 16.13.2.3. By End User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Delivery Mode 16.14.2.2. By Indication 16.14.2.3. By End User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Delivery Mode 16.15.2.2. By Indication 16.15.2.3. By End User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Delivery Mode 16.16.2.2. By Indication 16.16.2.3. By End User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Delivery Mode 16.17.2.2. By Indication 16.17.2.3. By End User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Delivery Mode 16.18.2.2. By Indication 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Delivery Mode 16.19.2.2. By Indication 16.19.2.3. By End User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Delivery Mode 16.20.2.2. By Indication 16.20.2.3. By End User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Delivery Mode 16.21.2.2. By Indication 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Delivery Mode 16.22.2.2. By Indication 16.22.2.3. By End User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Delivery Mode 16.23.2.2. By Indication 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Delivery Mode 17.3.3. By Indication 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. AngioDynamics Inc. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Boston Scientific Corporation 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. iVascular SLU 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Straub Medical AG 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Thrombolex Inc. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Teleflex Incorporated 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Straub Medical AG 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Penumbra, Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Medtronic Plc 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Inari Medical, Inc. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports